Improved Outcomes Using Tacrolimus/Sirolimus for Graft Versus Host Disease prophylaxis with a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis

Allogeneic hematopoietic cell transplantation (HCT) using reduced intensity conditioning (RIC) regimens is a potentially curative treatment for patients (patients) with myelofibrosis (MF), as we (1) and others have reported. Non-relapse mortality (NRM) from Graft vs. Host Disease (GVHD) and other co...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Snyder, David S., Palmer, Joycelynne, Gaal, Karl, Stein, Anthony S., Pullarkat, Vinod, Sahebi, Firoozeh, Vora, Nyana, Nakamura, Ryotaro, Forman, Stephen J.
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2819616/
https://ncbi.nlm.nih.gov/pubmed/19786111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.09.020
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares